Connect with us

Hi, what are you looking for?

Economy

US to share up to 60M AstraZeneca vaccine doses globally

WASHINGTON — The United States will start to share up to 60 million doses of AstraZeneca Plc’s coronavirus vaccine with other countries as soon as the next few weeks, the White House said on Monday.

White House Press Secretary Jen Psaki said the United States would release the doses to other countries as they become available.

She said there could be 10 million doses cleared for export “in coming weeks.” About 50 million more doses are currently being produced and could ship in May and June.

“Right now we have zero doses available of AstraZeneca,” Ms. Psaki said, noting that US regulators still need to review the quality of those already produced.

Ms. Psaki said the Biden administration is still deciding what the process will be to determine where and how it will share the vaccine.

“We will consider a range of options from our partner countries and, of course, much of that will be through direct relationships,” she said.

The AstraZeneca vaccine has not yet been authorized for US use by the Food and Drug Administration (FDA). The Biden administration in March said it would send roughly 4 million doses of the British drug maker’s vaccine to Canada and Mexico, and is under growing pressure now to expand sharing of its stockpile with India and other countries.

India has become the latest epicenter of the pandemic, threatening to overwhelm its healthcare system.

An AstraZeneca spokeswoman could not comment on specifics of the arrangement, but said the doses were part of its supply commitments to the US government. “Decisions to send US supply to other countries are made by the US government,” she said.

The Associated Press (AP) earlier on Monday reported the doses would be shared in coming months following their clearance by the FDA.

The AP reported that the doses were made at the Emergent BioSolutions facility in Baltimore, which came under harsh criticism for a long list of cleanliness and manufacturing problems found during an FDA inspection.

AstraZeneca is no longer making vaccines at that plant after a batch of Johnson & Johnson’s vaccine was ruined by contamination with ingredients from the AstraZeneca shot.

J&J is now overseeing production of its vaccine at the Emergent plant. — Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Latest

Economy

By Jenina P. Ibañez, Reporter PHILIPPINE INDUSTRIES are struggling with higher import costs caused at least in part by global supply chain constraints amid...

Economy

ELECTRONICS EXPORTS growth this year could exceed the initial target if supply chain limitations are resolved, the industry group’s top official said. Semiconductor and...

Economy

CAR SALES in May increased by more than four times from the same month last year after coming off a low base. A joint...

Economy

A SECURITIES and Exchange Commission (SEC) panel revoked the license and slapped a P32-million fine on Venture Securities, Inc. (VSI) and key officers over...

Economy

Grid operator says department policy will not eliminate brownouts By Angelica Y. Yang, Reporter THE Department of Energy (DoE) told privately owned National Grid...

Economy

STREAMING your favorite hour-long television show is the environmental equivalent of boiling a kettle for six minutes or popping four bags of popcorn in...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Economy

US President Joseph R. Biden, Jr., will rely on ally countries to supply the bulk of the metals needed to build electric vehicles and focus on...

Economy

THE Securities and Exchange Commission (SEC) has warned the public from investing or to stop any investment in a group named Maxxprofit Computer Trading...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.



Your information is secure and your privacy is protected. By opting in you agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!